TACTICS FOR ASSIGNMENT OPIOID ANALGESICS FOR RELIEVING CHRONIC PAIN IN ELDERLY PATIENTS


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The article analyzes the most frequent causes and characteristics of chronic pain phenomenon in the elderly that should be considered when analgesic therapy is provided. It is emphasized that the core task today is to develop the tactics of opioids use in non-cancer patients. While administering opioids for patients with a favorable life prognosis the pain control tactics is dedicated (alongside with getting rid of pain and its persistency prevention) to addiction prevention that dictates the use of opioids only for pain exacerbation control. The classical pain pharmacotherapy scheme should take into account the factors that reduce the risk of tolerance and dependence. Opioids and non-opioids combination should be used. In addition, it is necessary to consider that during analgesic therapy (especially in patients aged 75 years and older) it is difficult to select the optimal dose of opioids and to predict the adverse reactions risk which requires respecting the principle of «start with small doses and increase the dose gradually.» In order to determine the optimum tactics of analgesic therapy in elderly patients the authors have studied the efficacy and tolerability of a combined drug containing low doses of Tramadol Hydrochloride and low doses of Paracetamol (cTP) in these age group representatives. Adequate pain control was achieved in 85.7% patients, including complete and sufficient -in 57.1%, satisfactory - in 28.6% patients. Adverse side effects were observed in 7.2% of patients. Herewith most of them were unbinding. The study results allow recommending cTP as the first line remedy for chronic pain control in the elderly with low pharmacological risks.

Texto integral

Acesso é fechado

Sobre autores

A. Palekhov

SBEI HPE "Stavropol State Medical University"; SBHCI SR "Stavropol Regional Clinical Oncological Dispensary"

Email: docpaIekhova@mail.ru
Teaching Assistant at the Department of Oncology, Radiology and Radiotherapy; Chief Specialist of the Ministry of Health of the Stavropol Region for the treatment ofpain Stavropol

E. Vvedenskaya

SBHCI NNR “Nizhny Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases"

Nizhny Novgorod

Bibliografia

  1. Доклад Генерального секретаря ООН. Комиссия по народонаселению и развитию. Сорок седьмая сессия. 7-11 апреля 2014 года. http://www.un.org/ru/development/ surveys/demographic.shtml
  2. Шабунова А.А., Барсуков В.Н. Тенденции демографического старения населения Российской Федерации и пути их преодоления. Проблемы развития территории. 2015;Вып. 1(75):76-87.
  3. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2015;386(9995):743-800
  4. Злокачественные новообразования в России в 2014 году (заболеваемость и смертность) / Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2016. 250 с.
  5. Ferrell B.A., Ferrell B.R., Rivera L. Pain in cognitively impaired nursing home patients. J. Pain Symptom Manage. 1995;10:591-98.
  6. Molton I.R., Terrill A.L. Overview of Persistent Pain in Older Adults. Am. Psychol. 2014;69(2):197-207.
  7. Lipton R.B., Pfeffer D., Newman L.C., Solomon S. Headaches in the elderly. J. Pain Sympt. Manag. 1993;8:87-97.
  8. Sternbach R.A. Survey of pain in the United States: the Nuprin pain report. Clin. J. Pain. 1986;2:49-53.
  9. Valkenburg H.A. Epidemiological considerations of the geriatric population. Gerontology. 1988;34(Suppl. I):2-10.
  10. American Geriatrics Society Panel. Pharmacological Management of Persistent Pain in Older Persons. JAGS. 2009;57:1331-46.
  11. Donald I.P, Foy C. A longitudinal study of joint pain in older people. Rheumatology. 2004;43:1256-60.
  12. Thomas E., Peat G., Harris L., et al. The prevalence of pain and pain interference in a general population of older adults. Pain. 2004;110:361-68.
  13. Яхно Н.Н.(ред). Боль. М., 2009. 304 с.
  14. Helme R.D., Gibson S.J. The epidemiology of pain in elderly people. Clin. Geriatr. Med. 2001;17:417-31.
  15. Miro J., Paredes S., Rull M., Queral R., Miralles R., Nieto R., Huguet A., Baos J. Pain in older adults: a prevalence study in the Mediterranean region of Catalonia. Eur. J. Pain. 2007;11(1):83-92.
  16. Левин О.С., Штульман Д.Р Неврология: справочник практического врача. 7-е изд., доп. и перераб. М., 2011. 1016 с.
  17. Langley P.C. The prevalence, correlates and treatment of pain in the European Union. Curr. Med. Res. Opin. 2011;27(2):463-80.
  18. Molton I.R., Terrill A.L. Overview of Persistent Pain in Older Adults. Am. Psychol. 2014;69(2):197-207.
  19. Кукушкин М.Л., Хитров Н.К. Общая патология боли. М., 2004. 144 с.
  20. Pergolizzi J., Böger R.H., Budd K., Dahan A., Erdine S., Hans G., Kress H.G., Langford R., Likar R., Raffa R.B., Sacerdote P. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxyodone). Pain Pract. 2008;8(4):287-313.
  21. Schuler M., Grießinger N. Opioids for noncancer pain in the elderly. Schmerz. 2015;29(4): 380-401.
  22. Осипова Н.А., Абузарова Г.Р., Петрова В.В. Принципы применения анальгетических средств при острой и хронической боли. М., 2011. 72 с.
  23. Pharmacological Management of Persistent Pain in Older Persons. American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. J. Am. Geriatr. Soc. 2009;57(8):1331-46.
  24. Палехов А.В. Выбор опиоидной терапии боли как критерий качества оказания паллиативной медицинской помощи. Паллиативная медицина и реабилитация. 2013;(3):23-6.
  25. Палехов А.В. Наркотические лекарственные средства в России. Врач. 2013;(4):2-5.
  26. Палехов А.В., Николаева Н.М. Доступность адекватной опиоидной терапии в Российской Федерации. Заместитель главного врача: лечебная работа и медицинская экспертиза. 2014;101(10):6-14.
  27. Палехов А.В., Введенская Е.С. Проблемы опиоидной терапии больных с хроническим болевым синдромом и пути их решения. Заместитель главного врача: лечебная работа и медицинская экспертиза. 2015;10:44-51.
  28. Палехов А.В., Введенская Е.С. Опиоидные анальгетики в терапии хронической боли: проблемы и перспективы. Российский журнал боли. 2015;3-4(45):56-63.
  29. Данилов А.Б., Голубев В.Л. О концептуальной модели перехода острой боли в хроническую. Русский медицинский журнал. 2009;Спец. вып. «Болевой синдром»:11-4.
  30. Кукушкин М.Л. Механизмы хронизации болевых синдромов. Патогенез. 2005;3(1):16-7.
  31. Кукушкин М.Л. Механизмы развития и прин ципы этиопатогенетической терапии хронической боли. Журнал неврол. и психиатр. им. С.С. Корсакова. 2012;(2):89-94.
  32. Яхно Н.Н., Кукушкин М.Л. Дисфункциональный механизм хронической боли. Российский журнал боли. 2014;(1):23-24.
  33. Bennett R.M., Kamin R., Rosenthal N. Tramadol and acetaminophen in the treatment of fibromyalgia pain: a double blind randomized placebo-controlled study. Am. J. Med. 2003;114:537-45.
  34. Botting R.COX-3: mechanism of acetaminophen/ paracetamol analgesia. «PainPractice», Book of Abstracts 3rd World Congress World Institute of Pain, Barœlona. 2004. Р 194.
  35. Mischkowski D., Crocker J., Way B.M. From painkiller to empathy killer: acetaminophen (paracetamol) reduces empathy for pain. Soc. Cogn. Affect Neurosci. 2016.
  36. Bertolini A., Ferrari A., Ottani A., et al. Paracetamol: new vistas of an old dru. CNS Drug Rev. 2006;12(3-4):250-75.
  37. Осипова Н.А. Парацетамол/трамадол (Залдиар) - новый перспективный комбинированный ненаркотический анальгетик. Русский медицинский журнал: Независимое издание для практикующих врачей. 2005;13(12):803-6.
  38. Australian Public Assessment Report for Tramadol hydrochloride / Paracetamol Proprietary Product Name: Zaldiar. September, 2012. P. 152.
  39. Serrie A., Jouve E., Creuz'e A., Ganry H., Bloch O. Efficacy and Safety of Paracetamol (325 MG)-Tramadol (37.5 MG) Combination (PTC) in Elderly Patients: a PMS in General Przctice. Eur. J. Pain. 2009(13):S55-S285.
  40. Papaleontiou M., Henderson C.R. Jr, Turner B.J., Moore A.A., Olkhovskaya Y., Amanfo L., Reid M.C. Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis. J. Am. Geriatr. Soc. 2010;58(7):1353-69.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2016

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies